Tolterodine (trade names Detrol, Detrusitol) is an antimuscarinic drug that is used for symptomatic treatment of urinary incontinence.

The global Tolterodine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Tolterodine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tolterodine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Tolterodine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Tolterodine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Teva
Mylan
Impax Laboratories
Ranbaxy
Sandoz
Torrent Pharma
Macleods Pharmaceuticals
HETERO
NANJING ZENKOM PHARMACEUTICAL
Nanjing meirui pharma
DIKANG
ANHUI GLOBE PHARMACEUTICAL

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Capsules
Tablets

Segment by Application
Hospital
Drug store